Ibotta, Inc. <IBTA.N>: Wells Fargo raises target price to $40 from $38
IBTA•Related News
Dick’s Sporting Goods schedules fiscal Q2 earnings release, conference call
DKS•
Mineralys Therapeutics to report Q2 results, host conference call
MLYS•
Real, RE/MAX set Aug. 18 election deadline for RE/MAX holders in pending acquisition
REAX•
Rein Therapeutics publishes first-in-human LTI-03 idiopathic pulmonary fibrosis data in Nature Communications
RNTX•
YD Bio highlights peer-reviewed computational study nominating keratoconus regenerative therapy targets
YDES•